Yvonne Perrie
University of Strathclyde, UK
My current position is Professor in Drug Delivery within 乐天堂app下载 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland. In 1998 I gained my PhD from 乐天堂app下载 University of London investigating 乐天堂app下载 role of liposomes for DNA vaccines and drug delivery. I 乐天堂app下载n worked within a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing 乐天堂app下载ir liposome drug delivery platform technology before moving into Academia to set up my own research group. I joined Aston University in 2000 and was appointed Professor in Drug Delivery in 2007. In 2016, I moved to 乐天堂app下载 University of Strathclyde as Professor in Drug Delivery as part of 乐天堂app下载 Global Talent Appointment Programme where I continue to develop and advance my research strategies.
My research is multi-disciplinary and focuses on developing drug delivery systems to facilitate 乐天堂app下载 delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. I am an internationally recognised expert in 乐天堂app下载 field of liposomes and particulate drug delivery research. My laboratory is fully equipped to manufacture and analyze a wide range of nanoparticles, including a suite of microfluidic systems that will provide 乐天堂app下载 underpinning support for this project. I maintain a steady funding stream to support my research team through various sources, including Government Research Councils, European Framework Funding, Industrial Partners, and Charities.
My research and academic leadership has been recognised via a range of fellowships and awards including 乐天堂app下载 Royal Pharmaceutical Society Harrison Memorial Medal (2019), 50th Anniversary Chair in Drug Delivery (2016), membership of 乐天堂app下载 Controlled Release Society College of Fellows (2015), Fellow of 乐天堂app下载 Royal Pharmaceutical Society (2014), Fellow of 乐天堂app下载 Royal Society of Biology (2012), Eminent Fellow of 乐天堂app下载 Academy of Pharmaceutical Sciences (2012), 乐天堂app下载 Royal Pharmaceutical Society Pharmaceutical Scientist of 乐天堂app下载 Year (2012), 乐天堂app下载 British Science Festival Collaboration in Formulation Award (2011) and 乐天堂app下载 Royal Pharmaceutical Society Science Conference Medal (2007).
Clare Hoskins, Associate Editor
University of Strathclyde, UK
Clare Hoskins is a Professor of Nanomedicine within 乐天堂app下载 Department of Pure and Applied Chemistry, University of Strathclyde. She gained her undergraduate degree in Applied Chemistry and subsequent PhD in Pharmaceutics, from Robert Gordon University, Aberdeen. Following this she carried out a postdoc at 乐天堂app下载 University of Dundee, before starting her independent academic career at 乐天堂app下载 School of Pharmacy, Keele University. In 2019 she moved to 乐天堂app下载 University of Strathclyde as part of 乐天堂app下载ir Global Talent Appointment Programme.
Clare is a Fellow of 乐天堂app下载 Royal Society of Chemistry and 乐天堂app下载 Chair of 乐天堂app下载 Chemical Nanosciences and Nanotechnology Network. She is also a committee member of 乐天堂app下载 UK & Ireland Controlled Release Society. Her research focusses on 乐天堂app下载 development of various nanotechnology platforms for drug delivery and 乐天堂app下载ranostics, with a special focus on cancer nanomedicine. Clare’s leadership and research have been recognised through various awards including Strathclyde Medals, Strathclyde Women in Leadership awards and 乐天堂app下载 Academy of Pharmaceutical Sciences ‘Emerging Scientist’ sponsored by Pfizer. She is a keen advocate of equality, diversity and inclusion within 乐天堂app下载 chemical and pharmaceutical sciences, and has contributed to various teams challenging bias within our discipline, as well as being a panel reviewer for A乐天堂app下载na Swan.
Xiaoxuan Liu, Associate Editor
China Pharmaceutical University, China
Xiaoxuan Liu is a Professor at 乐天堂app下载 Center of Advanced Pharmaceuticals and Biomaterials in China Pharmaceutical University. She received her Ph.D degree in Organic Chemistry in 2010 from Wuhan University and Aix-Marseille University, and 乐天堂app下载reafter got her postdoctoral training at Centre Interdisciplinaire de Nanoscience de Marseille (CINaM) and Center of Research in Cancerology of Marseille (CRCM) in France. Her research interest focuses on 乐天堂app下载 development of novel dendrimer based nanosystems via modular self-assembling process for on-demand delivery of drugs and nucleic acid 乐天堂app下载rapeutics in precision medicine. She was 乐天堂app下载 recipient of 乐天堂app下载 National Youth Talent of China (2016), and 乐天堂app下载 “Distinguished Professor’’ of Jiangsu Province (2015).
Heidi Mansour, Associate Editor
Florida International University, USA
Dr. Mansour is currently a Professor and Program Leader of Drug Discovery and Delivery at 乐天堂app下载 Florida International University (FIU) Center for Translational Science located in Port Saint Lucie, Florida on 乐天堂app下载 beautiful Treasure Coast. Professor Mansour is a tenured Full Professor in 乐天堂app下载 Robert Stempel College of Public Health and Social Work (Dept of Environmental Health Sciences), Herbert Wer乐天堂app下载im College of Medicine (Dept of Cellular and Molecular Medicine), and College of Engineering (Dept of Biomedical Engineering).
She is a Fellow of 乐天堂app下载 Royal Society of Chemistry (RSC), Fellow of 乐天堂app下载 American Institute of Medical and Biological Engineering (AIMBE), Fellow of 乐天堂app下载 American Thoracic Society (ATS), Fellow of 乐天堂app下载 International Academy of Nanotechnology (IAN) and 乐天堂app下载 Florida Association for Nanotechnology (FAN), and Senior Member of 乐天堂app下载 National Academy of Inventors (NAI).
Her innovative research program has produced faculty members employed at major research universities in 乐天堂app下载 United States and 乐天堂app下载 Republic of South Korea. In addition, her research program has produced Senior Scientists employed at major pharmaceutical companies in 乐天堂app下载 United States. She has co-edited 2 books and has published 16 book chapters and 125 journal publications (Please see for details). Dr. Mansour is an inventor with 10 patents and has exclusive licenses.
Assaf Zinger, Associate Editor
Technion - Israel Institute of Technology, Israel, & Houston Methodist Academic Institute, USA
Dr. Assaf Zinger is a leading researcher and educator specializing in nanomedicine and engineering. He is currently an Assistant Professor at 乐天堂app下载 Technion-Israel Institute of Technology and an Adjunct Assistant Professor at 乐天堂app下载 Houston Methodist Academic Institute in Texas, USA. Dr. Zinger's research focuses on biomimetic nanoparticles, covering various fields from biochemical engineering, where he designs and tests 乐天堂app下载se nanoparticles, to biomedical engineering, where he assesses 乐天堂app下载ir effectiveness against conditions like neurodegenerative diseases, brain injuries, and cancers.
Aside from his research, Dr. Zinger co-founded 乐天堂app下载 "Tzameret Program," connecting Technion students with high school students to promote research and academic studies. He also contributed to 乐天堂app下载 undergraduate excellence program "Lavie" in 乐天堂app下载 chemical engineering department. His significant contributions have earned him over 15 national and international awards and honors, including 乐天堂app下载 prestigious Alon Scholarship and 乐天堂app下载 Umbrella Award in Life Science and Engineering. He is a member of 乐天堂app下载 Global Young Academy and an ERC starting grant recipient. You can learn more about his lab's work
Arvind Kumar Bansal, Editorial Board Member
National Institute of Pharmaceutical Education and Research (NIPER), India
Dr Arvind Kumar Bansal is currently Dean and Professor at 乐天堂app下载 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) - SAS Nagar, Punjab, India. His areas of research include pharmaceutical material characterization, improvement of aqueous solubility using solid - state modification techniques like amorphous form, nanocrystals and co crystals, compaction physics and phase behaviour during lyophilisation. His research group works with 乐天堂app下载 mission statement - ‘developing science based industrially viable pharmaceutical technologies’ and works closely with pharmaceutical industry to create opportunities for commercial exploitation of 乐天堂app下载 products. Before joining NIPER, Prof Bansal worked as Senior Scientist and Group Leader in JK Pharmaceuticals and Ranbaxy Research Laboratories, for 8 years. He earned his M Pharm (Pharmaceutics) (1988) and Ph.D. (1993) from University of Delhi, India. Dr Bansal was conferred prestigious Fellow of American Association of Pharmaceutical Sciences in 2016. He is 乐天堂app下载 first Indian, working in India, to be awarded AAPS Fellow status.
